The Edit Review: $209 Semaglutide, $309 Tirzepatide

We screened seven telehealth sellers together in August 2026, none of which pays us anything, and The Edit is the one whose numbers survived every arithmetic check we ran. That is a narrower compliment than it sounds, and a rarer one. Most of this market fails on the maths before it fails on the medicine.

The rungs we filed

Semaglutide is $209 a month and tirzepatide is $309 a month on the recurring, cancel-anytime rung. There is no membership fee, no consult charge stacked beside it and no minimum term.¹

Prepay is offered on both molecules: semaglutide at $575 once for three months or $1,065 once for six, tirzepatide at $855 for three or $1,575 for six. Each is labelled as billed once at the start of the plan, and each per-month figure printed beside it is honest — $575 over three months is $192, $1,065 over six is $178, $855 over three is $285, $1,575 over six is $263.¹

Spend a week reading price pages in this category and you learn to check that division first, because the single most common way a provider arrives at the bottom of a cost board is a prepay total presented as a monthly rate. Run the same ladder through our true-cost calculator and the six-month rung is genuinely the cheaper path here, not a rebadged commitment. That is the exception, not the norm — see what compounded GLP-1 really costs per month for how wide the honest range actually is.

The advertised number is a coupon

The Edit fronts $109 semaglutide and $209 tirzepatide. Both are the standing price minus a flat $100 off a first order. They are not rates you can hold. If you are budgeting six months of treatment — which is the horizon the trial data is written in — the numbers to plan against are $209 and $309, or the prepay totals above.

We file the recurring rung for exactly this reason, and it is why our semaglutide ruling never reads like the ad copy on anybody's homepage.

What else is on the shelf

Beyond the two GLP-1 protocols there are four more: injectable NAD+ at $249 a month, injectable glutathione at $199, injectable sermorelin at $169, and a GHK-Cu cream at $129.¹ Six protocols, five of them injectable, and nothing else.

What is absent matters more than what is present. No oral GLP-1, no nasal line, no retatrutide, and the site states in its own words that it does not sell research-use-only compounds. A prescription catalogue with no investigational shelf bolted onto the side of it is a decision somebody made, and it is the decision we would want made.

Who signs the prescription

Clinical work runs through Arora Health & Aesthetics, LLC, whose medical director is Dr. Sean Arora. His NPI — 1841729449 — resolves in the national registry to an active Family Medicine record in Seattle, Washington.² Dispensing is attributed to The Pharmacy Hub, named outright rather than described as an unnamed partner. The legal entity is The Edit Health LLC, a Texas company operating as a management services organisation, with a published Austin address. All 50 states.

Naming a prescriber and naming a pharmacy are the two checks in our provider checklist that most of this cohort fails. The Edit clears both, which is also the standard we set out in is compounded semaglutide legit and safe.

One caveat belongs here rather than in a footnote. Trellis Vitality uses the same medical group and the same medical director. Different pharmacy, different prices, genuinely separable products — but if you shortlist both you are shortlisting one clinical organisation twice, and a second opinion from the same medical director is not a second opinion.

The Spanish mirror is real

The Edit ships a complete Spanish version of every page, with 33 Spanish URLs declared in its own sitemap. Almost nobody in this market does that; the usual approach is a translated landing page in front of an English intake. If Spanish is the language you want your titration instructions in, this is a material difference rather than a marketing one.

What we checked, and what we could not

We queried the FDA's live warning-letter index for the trading name, the legal entity, the medical group and the named pharmacy. Nothing matched in the company column.³ That result is worth something only because the same pass, run identically, correctly returned a known February 2026 letter for an unrelated telehealth seller we used as a control — an empty result from a broken query looks exactly like a clean record, which is why the control exists.

What we could not do is reach a checkout price. The intake is questionnaire-walled and its scripts carry no price table, so the ladder above is the published ladder, corroborated across two of The Edit's own surfaces rather than confirmed at the point of sale. Getting started is free — the site states there is no charge and no card on file to begin, with a full refund if you are not approved — and compounded medication is final sale once shipped, which is standard across the category.

The ruling

If what you want is a price that will still be the price in month four, The Edit is the strongest of the seven providers we screened in this batch. It is not the cheapest of them: Pepti lists $99 semaglutide, Trellis Vitality $150, and Auren Rx $199. It is the one where every published figure held up under division. Read it against the rest of our evidence library, and against the ranked board at our provider reviews, before you decide what you are actually optimising for.